Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 vs LL-37: Research Comparison

The following table compares the core research characteristics, mechanisms, and experimental contexts where each peptide demonstrates efficacy. This is not a ranking—each peptide excels in its domain. Primary Mechanism Angiogenesis, collagen synthesis, growth

This comparison does not assign a generated winner or score.

  • The following table compares the core research characteristics, mechanisms, and experimental contexts where each peptide demonstrates efficacy. This is not a ranking—each peptide excels in its domain.
  • Primary Mechanism
  • Angiogenesis, collagen synthesis, growth factor upregulation (VEGF, TGF-β)
  • Antimicrobial membrane disruption, LPS neutralization, immune cell chemotaxis
  • Non-overlapping: one builds tissue, the other kills pathogens
  • Amino Acid Length
  • 15 amino acids (synthetic gastric peptide fragment)
  • 37 amino acids (cleaved from hCAP-18 precursor)
  • Structural difference dictates mechanism—BPC-157 is flexible signaling molecule, LL-37 is membrane-active helix
  • Target Pathways
  • FAK-paxillin, VEGFR, TGF-β receptor signaling
  • FPR2 receptor, TLR signaling, direct lipid bilayer interaction
  • Pathway specificity prevents substitution in protocols
  • Research Use Cases
  • Tendon/ligament repair, gastric ulcers, IBD models, muscle injury, neuroprotection
  • Wound infection, sepsis models, antimicrobial resistance, immune modulation, biofilm disruption
  • Select based on endpoint: tissue regeneration = BPC-157, infection control = LL-37
  • Stability
  • Stable at room temperature, resistant to gastric acid (oral administration viable)
  • Susceptible to proteolytic degradation, requires controlled storage (2–8°C post-reconstitution)
  • BPC-157 offers handling advantage for oral or extended-duration studies
  • Dosage Range (Preclinical)
  • 10–500 mcg/kg in rodent models, dose-dependent angiogenic response
  • 1–20 mg/kg in infection models, concentration-dependent antimicrobial and immunomodulatory effects
  • Dosage optimization depends on model type and administration route
More references

Related material

Comparison

Local Versus Systemic Injection

For specific injuries, injecting 1 to 2 inches from the injury site delivers high local concentration while still providing systemic benefits. For vagal and neurological effects, …

View details →